Hodgkin's lymphoma in adolescents

Journal of Clinical Oncology

Volumn 24, Issue 16, 2006, Pages 2520-2526

  Foltz, Lynda M ^b   Song, Kevin W ^b   Connors, Joseph M ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE; ABVD PROTOCOL; ANTINEOPLASTIC AGENT; MOPP PROTOCOL;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CANADA; DISEASE FREE SURVIVAL; INCIDENCE; MEDICAL RECORD; PATHOLOGY; PROSPECTIVE STUDY; REGISTER; RISK ASSESSMENT; SECOND CANCER; SURVIVAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; BRITISH COLUMBIA; CHEMOTHERAPY, ADJUVANT; DACARBAZINE; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; HODGKIN DISEASE; HUMANS; INCIDENCE; MALE; MECHLORETHAMINE; MEDICAL RECORD LINKAGE; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; PREDNISONE; PROCARBAZINE; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; REGISTRIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VINBLASTINE; VINCRISTINE;

EID: 33744986066     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.04.5823     Document Type: Article

References (16)

1. Yung L, Linch D: Hodgkin's lymphoma. Lancet 361:943-951, 2003
2. Ekstrand BC, Horning SJ: Hodgkin's disease. Blood Rev 16:111-117, 2002
3. Canellos GP, Anderson JR, Propert KJ, et al: Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med 327:1478-1484, 1992
4. Diehl V, Franklin J, Pfreundschuh M, et al: Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease. N Engl J Med 348:2386-2395, 2003
5. Horning SJ, Hoppe RT, Breslin S, et al: Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: Mature results of a prospective clinical trial. J Clin Oncol 20:630-637, 2002
6. Schellong G, Potter R, Bramswig J, et al: High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: The German-Austrian multi-center trial DAL-HD-90: The German-Austrian Pediatric Hodgkin's Disease Study Group. J Clin Oncol 17:3736-3744, 1999
7. Mottl AM, Fisher SG, Fisher RI, et al: Adolescents with hodgkin lymphoma treated on adult and pediatric protocols have distinct therapeutic outcome. Blood 104:312, 2004
8. Hasenclever D, Diehl V: A prognostic score for advanced Hodgkin's disease: International prognostic factors project on advanced Hodgkin's disease. N Engl J Med 339:1506-1514, 1998
9. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Statist Assoc 53:457-481, 1958
10. Peto R, Peto J: Asymptotically efficient rank invarian test procedures. J Roy Statist Soc 135:185-207, 1972
11. Weiner MA, Leventhal B, Brecher ML, et al: Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: A Pediatric Oncology Group study. J Clin Oncol 15:2769-2779, 1997
12. Yung L, Smith P, Hancock BW, et al: Long term outcome in adolescents with Hodgkin's lymphoma: Poor results using regimens designed for adults. Leuk Lymphoma 45:1579-1585, 2004
13. Lin HM, Teitell MA: Second malignancy after treatment of pediatric Hodgkin disease. J Pediatr Hematol Oncol 27:28-36, 2005
14. Swerdlow AJ, Barber JA, Hudson GV, et al: Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: The relation to age at treatment. J Clin Oncol 18:498-509, 2000
15. Dores GM, Metayer C, Curtis RE, et al: Second malignant neoplasms among long-term survivors of Hodgkin's disease: A population-based evaluation over 25 years. J Clin Oncol 20:3484-3494, 2002
16. Bhatia S, Yasui Y, Robison LL, et al: High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: Report from the Late Effects Study Group. J Clin Oncol 21:4386-4394, 2003